This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
 NHF In The News
 NHF eNotes
 Medical Advisories
 Advocacy and Legislative Updates
 Medical News
 Blood Safety News
-NHF and Community News
 Industry News
 Travel Advisory



NHF Announces 2009 Clinical Fellowship Awardees

The National Hemophilia Foundation (NHF) is pleased to announce the recipients of the 2009 NHF-Baxter Clinical Fellowship. This year’s recipients are Salley Pels, MD, Yale University and Jeremiah Boles, MD, University of North Carolina (UNC) at Chapel Hill.

Funded through the generous support of Baxter Healthcare Corporation, the NHF-Baxter Clinical Fellowship Program was conceived to address the need to attract new physicians to the field of nonmalignant hematology and further support quality training for these individuals at leading hemophilia and thrombophilia research institutions throughout the U.S. The program also aims to increase the number of skilled clinicians committed to hematology and provide them with broad-based training from a clinical and academic perspective.

Pels joined the hemophilia treatment center at Yale University as a pediatric hematology/oncology resident in 2004 after receiving her undergraduate degree from Johns Hopkins University and her MD from the University of Vermont College of Medicine. She recently authored a poster abstract on immune thrombocytopenia, which was selected for presentation at the 2009 Plenary Scientific Session of the Hemophilia & Thrombosis Research Society’s Annual Meeting.

As an NHF-Baxter Clinical Fellow, Pels will spend two years developing advanced skills in clinical hemostasis and learning rigorous methodologies of clinical trial design, completion and monitoring. She will also continue her work on several ongoing studies under the mentorship of Diana Beardsley, MD, PhD, associate professor and pediatric hematologist at Yale University.

Pels intends to pursue a career that includes both academics and research, including clinical work in the broad areas of hemostasis and thrombosis. She is hopeful that this work will lead to better therapies for patients with hemophilia as well as other bleeding and clotting disorders.

Boles is currently a hematology and oncology fellow with the University of North Carolina at Chapel Hill, where he received both his BS and MD. His fellowship mentor will be Nigel Key, MD, Harold R. Roberts Distinguished Professor and Director of the Hemophilia and Thrombosis Center at UNC.

The co-author of a number of publications, including many in the field of neuroscience, Boles has also been honored for his teaching skills. Training received during the course of the program will include rigorous laboratory research as well as career guidance in hemostasis.

Boles hopes to continue his career in hematology post-fellowship and conduct research that will improve the lives of patients with hemophilia and other bleeding disorders.

The NHF-Baxter Clinical Fellowship provides up to $100,000 per fellow, per year. Since the program’s inception in 2003, 19 clinicians have been selected as fellows by an independent review panel. Many graduates of this program have chosen to make a commitment to pursuing hematologic research and/or treating patients with bleeding and clotting disorders as their career. Baxter’s continued sponsorship of this fellowship program will support two additional fellows each year though 2011.



This section of our Web site is sponsored by: